HCV Seek, Test and Rapid Treatment for Young PWID

Completed · Not applicable

Conditions studied: Hepatitis C, Drug Use

In brief

The purpose of this randomized study is to determine whether a community-based test and treat model of hepatitis C (HCV) care delivery will be superior to the usual care practice of referral to specialist clinics for the outcomes of sustained virologic response at 12 weeks after treatment and initiation of HCV treatment for persons who inject drugs (PWID) between ages 18 and 29 who are naïve to HCV treatment

Key facts

Study ID

NCT03627546

Run by

Weill Medical College of Cornell University

People needed

39

Starts

2018-09-18

Expected to finish

2021-06-30

Last updated by the study team

2024-04-29

Who can join

Age: 18 and older, up to 29. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Persons are eligible for study inclusion if they: (a) are HCV antibody positive, (b) are 18 to 29 years of age, (c) have injected drugs in the past 30 days, (d) are HCV treatment naïve, (e) are English speaking

You may not qualify if…

• Persons excluded from the study will be (a) HIV coinfected persons (b) pregnant women, or women planning on becoming pregnant (c) participants with end-stage renal disease (d) participants with decompensated cirrhosis (c) participants on medications with treatment limiting interactions with sofosbuvir/velpatasvir

Where it is running

• Lower East Side Harm Reduction Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.